Medicenna Therapeutics Statistics

Total Valuation

MDNAF has a market cap or net worth of $105.44 million. The enterprise value is $75.82 million.

Market Cap	105.44M
Enterprise Value	75.82M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.00%
Owned by Institutions (%)	13.14%
Float	49.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.92
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.74, with zero debt.

Current Ratio	9.74
Quick Ratio	9.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -28.40% and return on invested capital (ROIC) is -61.09%.

Return on Equity (ROE)	-28.40%
Return on Assets (ROA)	-23.50%
Return on Capital (ROIC)	-61.09%
Revenue Per Employee	n/a
Profits Per Employee	-$547,188
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +173.84% in the last 52 weeks. The beta is 1.34, so MDNAF's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+173.84%
50-Day Moving Average	1.67
200-Day Moving Average	0.83
Relative Strength Index (RSI)	41.04
Average Volume (20 Days)	108,002

Short Selling Information

Short Interest	109,389
Short Previous Month	278,169
Short % of Shares Out	n/a
Short % of Float	0.22%
Short Ratio (days to cover)	0.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.43M
Pretax Income	-8.76M
Net Income	-8.76M
EBITDA	-8.75M
EBIT	-8.76M
Earnings Per Share (EPS)	-$0.13

Full Income Statement

Balance Sheet

The company has $29.62 million in cash and no debt, giving a net cash position of $29.62 million.

Cash & Cash Equivalents	29.62M
Total Debt	n/a
Net Cash	29.62M
Net Cash Per Share	n/a
Equity (Book Value)	26.90M
Book Value Per Share	n/a
Working Capital	28.25M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-13.82M
Capital Expenditures	n/a
Free Cash Flow	-13.82M
FCF Per Share	-$0.20

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MDNAF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.06%
Shareholder Yield	-24.06%
Earnings Yield	-8.30%
FCF Yield	-13.11%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1